24 results
424B3
TRML
Tourmaline Bio Inc
15 Sep 23
Prospectus supplement
6:31am
and training. Additionally, third-party payors may not cover, or provide adequate reimbursement for, long-term follow-up evaluations required
S-4/A
TRML
Tourmaline Bio Inc
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
, technologies and treatment practices that require additional upfront costs and training. Additionally, third-party payors may not cover, or provide
S-4
2rermi7wzt9w
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
d4flg0
22 Jun 23
Business combination disclosure
9:12am
8-K
EX-2.1
tgocavopn2xhwz
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
DEF 14A
ozp 8mxr05rf3
29 Apr 22
Definitive proxy
4:24pm
10-K
gm40z
17 Mar 22
Annual report
4:31pm
10-Q
pxs4c tczy93
14 Jun 21
Quarterly report
4:21pm